Hypoglycemia at Initiation of Pump Therapy in Children With Type 1 Diabetes
NCT01840358 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2013-04-26
Summary
The purpose of this study is to determine if patients have more hypoglycemic episodes the first 3 days following pump start compared to their usual number of hypoglycemias with our actual pump initiation protocol.
Conditions
Interventions
- OTHER
-
Observation of hypoglycemias frequency 3 days before and after pump initiation
Sponsors & Collaborators
-
St. Justine's Hospital
lead OTHER
Principal Investigators
-
patricia Olivier, Md · St. Justine's Hospital
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2013-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
NCT02402933 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Severe Hypoglycemia in Type 1 Diabetes
NCT00360984 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I Diabetes
NCT00147342 ·Status: COMPLETED
-
Assessing the Impact of Control-IQ Technology
NCT04838561 ·Status: COMPLETED
-
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
NCT01823341 ·Status: COMPLETED ·Phase: PHASE2
-
Insulin-based Strategies to Prevent Hypoglycemia During Exercise
NCT03349489 ·Status: UNKNOWN ·Phase: NA
-
Timing of Initiation of Continuous Glucose Monitoring in Established Pediatric Diabetes (The CGM TIME Trial)
NCT01295788 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes
NCT01586065 ·Status: COMPLETED ·Phase: NA
-
Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 Diabetes
NCT00109434 ·Status: COMPLETED
-
Interest of SmartGuard Technology (Predictive System for Stopping Insulin Before Hypoglycemia) in Children With Type 1 Diabetes Treated With Insulin Pump
NCT03882463 ·Status: COMPLETED ·Phase: NA
-
Prospective Study of the Impact of Insulin Pump Therapy in Young Children With Type 1 Diabetes
NCT00727220 ·Status: COMPLETED
-
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms
NCT02438189 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Omnipod DASH in Children and Adolescents With Type 1 Diabetes Mellitus
NCT05377385 ·Status: COMPLETED
-
Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes
NCT01828125 ·Status: WITHDRAWN ·Phase: PHASE2
-
Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.
NCT04664764 ·Status: UNKNOWN ·Phase: PHASE4
-
Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia
NCT00974051 ·Status: COMPLETED ·Phase: NA
-
Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
NCT02411578 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Optimized Titration and Delivery of Bedtime Insulin on Prevention of Nocturnal Hypoglycemia
NCT00475345 ·Status: COMPLETED ·Phase: NA
-
Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus Patients
NCT01525784 ·Status: UNKNOWN
-
Feasibility Study Assessing the Ability of an Insulin Pump-controlling Algorithm to Minimize Hypoglycemia
NCT01919385 ·Status: COMPLETED ·Phase: PHASE1
-
Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 Diabetes Mellitus (DM)
NCT01338922 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes
NCT00607503 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin
NCT03400501 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia
NCT04266379 ·Status: UNKNOWN ·Phase: NA
-
Hybrid Closed-Loop Control With Smart Prandial Insulin Dosing in Type 1 Diabetes
NCT04878120 ·Status: COMPLETED ·Phase: NA